Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernia, Ventral | 2 | 2023 | 220 | 0.810 |
Why?
|
| Mammaplasty | 10 | 2017 | 1263 | 0.800 |
Why?
|
| Sternum | 2 | 2022 | 177 | 0.780 |
Why?
|
| Abdominal Wall | 1 | 2023 | 167 | 0.770 |
Why?
|
| Surgical Flaps | 14 | 2010 | 1682 | 0.660 |
Why?
|
| Surgical Wound Infection | 4 | 2022 | 1545 | 0.650 |
Why?
|
| Mastectomy | 7 | 2023 | 1851 | 0.370 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2022 | 216 | 0.360 |
Why?
|
| Breast Implantation | 4 | 2015 | 224 | 0.360 |
Why?
|
| Mastectomy, Segmental | 2 | 2017 | 961 | 0.340 |
Why?
|
| Respiratory Tract Fistula | 1 | 2008 | 25 | 0.310 |
Why?
|
| Bronchial Fistula | 1 | 2008 | 83 | 0.300 |
Why?
|
| Tissue Expansion | 2 | 2023 | 163 | 0.300 |
Why?
|
| Nipples | 2 | 2009 | 230 | 0.290 |
Why?
|
| Breast | 3 | 2009 | 1975 | 0.290 |
Why?
|
| Pleural Diseases | 1 | 2008 | 138 | 0.290 |
Why?
|
| Pectoralis Muscles | 2 | 2022 | 86 | 0.260 |
Why?
|
| Debridement | 3 | 2022 | 492 | 0.260 |
Why?
|
| Omentum | 2 | 2005 | 168 | 0.250 |
Why?
|
| Patient Satisfaction | 5 | 2017 | 3486 | 0.240 |
Why?
|
| Sternotomy | 2 | 2022 | 132 | 0.230 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 492 | 0.220 |
Why?
|
| Abdominal Muscles | 1 | 2023 | 172 | 0.200 |
Why?
|
| Tissue Expansion Devices | 3 | 2014 | 160 | 0.200 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2002 | 238 | 0.190 |
Why?
|
| Neurotensin | 1 | 2021 | 60 | 0.180 |
Why?
|
| Atlases as Topic | 1 | 2022 | 248 | 0.180 |
Why?
|
| Surgical Mesh | 1 | 2023 | 316 | 0.170 |
Why?
|
| Spinal Neoplasms | 2 | 2005 | 716 | 0.170 |
Why?
|
| Adipose Tissue, White | 1 | 2022 | 371 | 0.160 |
Why?
|
| Salvage Therapy | 1 | 2005 | 1277 | 0.160 |
Why?
|
| Mammary Arteries | 1 | 1997 | 82 | 0.140 |
Why?
|
| Dextrans | 1 | 1999 | 574 | 0.140 |
Why?
|
| Lymphatic Vessels | 1 | 2021 | 356 | 0.140 |
Why?
|
| Thermogenesis | 1 | 2021 | 494 | 0.130 |
Why?
|
| Esthetics | 3 | 2017 | 330 | 0.130 |
Why?
|
| Breast Neoplasms | 6 | 2023 | 21162 | 0.130 |
Why?
|
| Infarction | 1 | 1997 | 247 | 0.130 |
Why?
|
| Calciphylaxis | 1 | 1997 | 130 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 684 | 0.120 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2014 | 491 | 0.110 |
Why?
|
| Elbow | 1 | 1994 | 130 | 0.110 |
Why?
|
| Erythema | 1 | 2014 | 261 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 2007 | 4981 | 0.100 |
Why?
|
| Retrospective Studies | 10 | 2023 | 81801 | 0.100 |
Why?
|
| Recurrence | 1 | 2023 | 8506 | 0.090 |
Why?
|
| Breast Implants | 4 | 2014 | 414 | 0.080 |
Why?
|
| Empyema | 1 | 2008 | 41 | 0.080 |
Why?
|
| Coronary Artery Bypass | 1 | 1997 | 2194 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2014 | 15881 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3587 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2022 | 3981 | 0.070 |
Why?
|
| Microsurgery | 2 | 2009 | 803 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 5192 | 0.070 |
Why?
|
| Sensation | 1 | 2009 | 337 | 0.070 |
Why?
|
| Middle Aged | 19 | 2017 | 223491 | 0.070 |
Why?
|
| Cancer Care Facilities | 1 | 2009 | 424 | 0.060 |
Why?
|
| Osteoradionecrosis | 1 | 2005 | 51 | 0.060 |
Why?
|
| Organ Size | 1 | 2010 | 2268 | 0.060 |
Why?
|
| Humans | 28 | 2023 | 768393 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2022 | 65379 | 0.060 |
Why?
|
| Rectus Abdominis | 2 | 2010 | 103 | 0.060 |
Why?
|
| Thorax | 1 | 2007 | 559 | 0.060 |
Why?
|
| Lumbosacral Region | 1 | 2005 | 294 | 0.060 |
Why?
|
| Female | 23 | 2023 | 397089 | 0.050 |
Why?
|
| Anticoagulants | 1 | 1999 | 4843 | 0.050 |
Why?
|
| Mastectomy, Radical | 1 | 2002 | 19 | 0.050 |
Why?
|
| Silicone Gels | 1 | 2002 | 39 | 0.050 |
Why?
|
| Transplantation, Autologous | 1 | 2007 | 2127 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 1704 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2021 | 418 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 1515 | 0.040 |
Why?
|
| Manubrium | 1 | 1998 | 8 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2005 | 1509 | 0.040 |
Why?
|
| Reoperation | 1 | 2009 | 4341 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2002 | 677 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 12241 | 0.040 |
Why?
|
| Time Factors | 4 | 2015 | 40272 | 0.040 |
Why?
|
| Algorithms | 1 | 2017 | 14154 | 0.030 |
Why?
|
| Skin Transplantation | 2 | 1998 | 1097 | 0.030 |
Why?
|
| Sodium Chloride | 2 | 2014 | 584 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2009 | 3627 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2002 | 2229 | 0.030 |
Why?
|
| Outpatients | 1 | 2023 | 1604 | 0.030 |
Why?
|
| Adult | 13 | 2014 | 223640 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1999 | 2226 | 0.030 |
Why?
|
| Necrosis | 1 | 1997 | 1621 | 0.030 |
Why?
|
| Piperidines | 1 | 2002 | 1659 | 0.030 |
Why?
|
| Bursitis | 1 | 1994 | 85 | 0.030 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2002 | 1167 | 0.030 |
Why?
|
| Hallux | 1 | 1993 | 43 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 4069 | 0.030 |
Why?
|
| Pressure Ulcer | 1 | 1994 | 159 | 0.030 |
Why?
|
| Adiposity | 1 | 2022 | 1895 | 0.020 |
Why?
|
| Amputation, Traumatic | 1 | 1993 | 135 | 0.020 |
Why?
|
| Leg Injuries | 1 | 1993 | 180 | 0.020 |
Why?
|
| Quality of Life | 2 | 2010 | 13503 | 0.020 |
Why?
|
| Thumb | 1 | 1993 | 232 | 0.020 |
Why?
|
| Sarcoma | 1 | 2002 | 1807 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2009 | 39407 | 0.020 |
Why?
|
| Hand Injuries | 1 | 1993 | 240 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 1994 | 771 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2906 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2022 | 3334 | 0.020 |
Why?
|
| Pyridines | 1 | 2002 | 2889 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2014 | 1149 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2002 | 6001 | 0.020 |
Why?
|
| Bone Neoplasms | 2 | 1998 | 2565 | 0.020 |
Why?
|
| Syndrome | 1 | 2014 | 3275 | 0.020 |
Why?
|
| Face | 1 | 1994 | 1031 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2002 | 5336 | 0.020 |
Why?
|
| New England | 1 | 2009 | 1058 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14481 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1997 | 2491 | 0.020 |
Why?
|
| Logistic Models | 2 | 2010 | 13323 | 0.010 |
Why?
|
| Mice | 2 | 2022 | 82017 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 13576 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8731 | 0.010 |
Why?
|
| Medical Records | 1 | 2009 | 1412 | 0.010 |
Why?
|
| Graft Survival | 1 | 1994 | 3900 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8753 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22355 | 0.010 |
Why?
|
| Wound Healing | 1 | 1994 | 2813 | 0.010 |
Why?
|
| Burns | 1 | 1994 | 1893 | 0.010 |
Why?
|
| Risk Factors | 3 | 2022 | 74962 | 0.010 |
Why?
|
| Male | 6 | 2021 | 364902 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 11854 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6241 | 0.010 |
Why?
|
| Aged | 6 | 2014 | 171562 | 0.010 |
Why?
|
| Melanoma | 1 | 1998 | 5705 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 13084 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1994 | 2923 | 0.010 |
Why?
|
| Animals | 2 | 2022 | 169337 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13697 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23631 | 0.010 |
Why?
|
| Health Status | 1 | 2009 | 4094 | 0.010 |
Why?
|
| Comorbidity | 1 | 2010 | 10588 | 0.010 |
Why?
|
| Maxillary Neoplasms | 1 | 1994 | 47 | 0.010 |
Why?
|
| Safety | 1 | 1998 | 1159 | 0.010 |
Why?
|
| Carcinoma in Situ | 1 | 1998 | 789 | 0.010 |
Why?
|
| Facial Injuries | 1 | 1994 | 191 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2002 | 6856 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1998 | 1094 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 1994 | 396 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1998 | 2925 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 1994 | 684 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 54920 | 0.010 |
Why?
|
| Skin Neoplasms | 2 | 1998 | 5857 | 0.000 |
Why?
|
| Adolescent | 2 | 2014 | 89184 | 0.000 |
Why?
|
| Young Adult | 1 | 2014 | 60049 | 0.000 |
Why?
|
| Carcinoma | 1 | 1998 | 2341 | 0.000 |
Why?
|
| Emergencies | 1 | 1993 | 1219 | 0.000 |
Why?
|
| Biopsy | 1 | 1998 | 6808 | 0.000 |
Why?
|
| Disease Progression | 1 | 2002 | 13646 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1998 | 11254 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1998 | 9433 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1994 | 42650 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1994 | 59686 | 0.000 |
Why?
|
| Child | 1 | 1994 | 80891 | 0.000 |
Why?
|
Concepts
(159)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_